Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Accumulated Expenses: 2019-2022

Historic Accumulated Expenses for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $68.5 million.

  • ADC Therapeutics' Accumulated Expenses fell 14.64% to $53.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $53.5 million, marking a year-over-year decrease of 14.64%. This contributed to the annual value of $68.5 million for FY2022, which is 35.63% up from last year.
  • As of FY2022, ADC Therapeutics' Accumulated Expenses stood at $68.5 million, which was up 35.63% from $50.5 million recorded in FY2021.
  • Over the past 5 years, ADC Therapeutics' Accumulated Expenses peaked at $68.5 million during FY2022, and registered a low of $15.4 million during FY2019.
  • Over the past 2 years, ADC Therapeutics' median Accumulated Expenses value was $59.5 million (recorded in 2021), while the average stood at $59.5 million.
  • Data for ADC Therapeutics' Accumulated Expenses shows a peak YoY soared of 35.63% (in 2022) over the last 5 years.
  • ADC Therapeutics' Accumulated Expenses (Yearly) stood at $15.4 million in 2019, then reached $50.5 million in 2021, then soared by 35.63% to $68.5 million in 2022.